| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $238K | — | — |
| Cost of Revenue | $14K | — | — |
| R&D Expense | $3.3M | — | -34.7% |
| SG&A Expense | $4.8M | — | -6.6% |
| Operating Income | -$23.7M | — | -15.3% |
| Net Income | -$26.1M | — | -25.6% |
| EPS (Basic) | -$0.20 | — | +35.5% |
| EPS (Diluted) | -$0.20 | — | +35.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $71.3M | -2.4% | +58.2% |
| Short-term Investments | $112.9M | +243.0% | +938.3% |
| Accounts Receivable | $1.6M | — | — |
| Inventory | $1.8M | +181.8% | — |
| Current Assets | $192.3M | +71.8% | +217.9% |
| Total Assets | $193.7M | +70.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.1M | — | -15.1% |
| Capital Expenditures | $45K | — | +650.0% |
| Investing Cash Flow | -$80.0M | — | -338.3% |
| Financing Cash Flow | $94.4M | — | — |
| Free Cash Flow | -$16.1M | — | -15.3% |
| +213.1% |
| Current Liabilities | $20.9M | +49.8% | +61.6% |
| Long-term Debt | $58.2M | +1.8% | +7.2% |
| Total Liabilities | $157.7M | +119.6% | +131.9% |
| Stockholders' Equity | $36.0M | -13.7% | +688.7% |